TrippBio, Inc.

TrippBio is developing a new, therapeutic application of an FDA-approved drug with a high probability to be proven safe and efficacious in the treatment and prevention of the SARS-CoV-2 virus that causes COVID-19.

Closed

science

platform logo

Total raised

updated 356 days ago

$185,796

17%

Funding goal

$10K- $1.0M

Minimum ticket

$ 100.00

Investors

Regulation

County Flag
C

EQUITY

Share price

$4

Number of securities

2,500

Discover our exclusive features for registered users

Understand when and how people have invested in a campaign with our hourly commitments and investor data.

Benefit from AI-powered company descriptions and other important information.

Access financial statements from various sources in one convenient location.

No subscription required - Wixdom is and will remain free to use! Register now to access our industry-leading crowdfunding data.

Sign up for free

Available soon

© 2020-2022 COLLISIO TECHNOLOGIES S.L.